10090sek
-0,2 %
Date:2025-11-28Time:18:00:00Latest report:Q3-2025List:Mid CapTicker:BIOG B
Market Cap:10 207 msekEnterprise Value:9 479 msekNet Sales:1 462 msekEarnings:315,9 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:100,90
MA50:104,04
MA200:105,29
Price/MA200:-4,2 %
RSI (14):44,6
Price/MA50:-3,0 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.